Inhibition of ultraviolet B radiation-induced interleukin 10 expression in murine keratinocytes by selenium compounds.
BACKGROUND
Selenium is an essential trace nutrient necessary for the normal function of the immune system. Selenium compounds protect mice against ultraviolet (UV) B-induced tumours, probably by preventing oxidative damage to the host skin cells and to the host immune system. One possible mechanism of protection is that selenium can prevent oxidative stress-induced release of cytokines such as interleukin (IL)-10, which could suppress cell-mediated immunity.


OBJECTIVE
To determine whether selenium compounds can inhibit UVB induction of IL-10 protein in murine keratinocytes.


METHODS
The murine keratinocyte cell line PAM 212 was treated with or without selenomethionine (50-200 nmol L-1) or sodium selenite (1-50 nmol L(-1)) for 24 h before exposure to 200 J m(-2) UVB. The cells were stained with an antibody to IL-10, 24 h after irradiation.


RESULTS
Preincubation with both selenium compounds inhibited UVB induction of IL-10 immunostaining, although selenomethionine was more effective. Pretreatment with 200 nmol L(-1) selenomethionine decreased IL-10 immunostaining to levels seen in the unirradiated controls.


CONCLUSIONS
The protective effects of selenium against UVB-induced skin cancer in murine models may result, in part, from its ability to inhibit release of cytokines that are capable of suppressing cell-mediated immunity.
Rafferty
T S
TS
Department of Dermatology, University of Edinburgh, Royal Infirmary of Edinburgh, Lauriston Building, Edinburgh EH3 9YW, UK.
Walker
C
C
Hunter
J A A
JA
Beckett
G J
GJ
McKenzie
R C
RC
D000818:Animals; D002460:Cell Line; D007111:Immunity, Cellular / Q000187:drug effects; D007150:Immunohistochemistry; D016753:Interleukin-10 / Q000276:immunology*; D015603:Keratinocytes / Q000276:immunology* / Q000528:radiation effects*; D051379:Mice; D018036:Selenium Compounds / Q000627:therapeutic use*; D012645:Selenomethionine / Q000627:therapeutic use; D018038:Sodium Selenite / Q000627:therapeutic use; D014466:Ultraviolet Rays / Q000009:adverse effects*
D018036:Selenium Compounds; D016753:Interleukin-10; D012645:Selenomethionine; D018038:Sodium Selenite